Lynn Bell, Louise Turtle, Tony Pope, David Cobben, Anoop Haridass
{"title":"152 一项回顾性审计,比较了使用 COVID-19 低分量疗法接受姑息性放疗的 NSCLC 患者与大流行前使用 RCR 推荐的标准疗法的患者的毒性和生存结果","authors":"Lynn Bell, Louise Turtle, Tony Pope, David Cobben, Anoop Haridass","doi":"10.1016/j.lungcan.2024.107713","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":507097,"journal":{"name":"Lung cancer","volume":"1472 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"152 A retrospective audit comparing toxicity and survival outcomes in patients who received palliative radiotherapy for NSCLC using the COVID-19 hypofractionated regime with patients treated pre-pandemic using standard RCR recommended regimes\",\"authors\":\"Lynn Bell, Louise Turtle, Tony Pope, David Cobben, Anoop Haridass\",\"doi\":\"10.1016/j.lungcan.2024.107713\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":507097,\"journal\":{\"name\":\"Lung cancer\",\"volume\":\"1472 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lung cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.lungcan.2024.107713\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.lungcan.2024.107713","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
152 A retrospective audit comparing toxicity and survival outcomes in patients who received palliative radiotherapy for NSCLC using the COVID-19 hypofractionated regime with patients treated pre-pandemic using standard RCR recommended regimes